beta Lactamase Inhibitor [EPC]

beta Lactamase Inhibitor [EPC] was reported 4449 times

Drugs of the beta Lactamase Inhibitor [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 SPIROMETRY ABNORMAL 69 0.1154
1 MITE ALLERGY 73 0.1115
2 MYCOTIC ALLERGY 70 0.0819
3 DUST ALLERGY 73 0.0744
4 PULMONARY VASCULITIS 36 0.0669
5 TOTAL LUNG CAPACITY ABNORMAL 23 0.0591
6 CONJUNCTIVITIS ALLERGIC 72 0.0486
7 CAPILLARITIS 12 0.0435
8 PROLONGED EXPIRATION 9 0.0344
9 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 24 0.0327
10 SUSPECTED DRUG-INDUCED LIVER INJURY 6 0.0300
11 NORMOCHROMIC NORMOCYTIC ANAEMIA 73 0.0243
12 NEURITIS 37 0.0239
13 SPUTUM PURULENT 14 0.0213
14 DEAFNESS PERMANENT 4 0.0204
15 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 34 0.0167
16 PRECANCEROUS CONDITION 10 0.0149
17 RESPIRATORY SYMPTOM 40 0.0140
18 BULIMIA NERVOSA 5 0.0114
19 THERAPEUTIC PRODUCT CROSS-REACTIVITY 10 0.0112
20 EXANTHEM 4 0.0111
21 GALLBLADDER CHOLESTEROLOSIS 5 0.0110
22 PERSONAL RELATIONSHIP ISSUE 7 0.0105
23 KOUNIS SYNDROME 23 0.0101
24 HEPATITIS CHOLESTATIC 49 0.0081
25 FORCED EXPIRATORY VOLUME DECREASED 23 0.0081
26 ARTERIOSCLEROSIS CORONARY ARTERY 53 0.0080
27 ARTERIOSCLEROSIS 74 0.0079
28 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 25 0.0077
29 MIXED LIVER INJURY 23 0.0076
30 CHOLESTATIC LIVER INJURY 17 0.0076
31 FULL BLOOD COUNT ABNORMAL 75 0.0071
32 FOETAL HEART RATE DECELERATION ABNORMALITY 5 0.0071
33 MOTOR DEVELOPMENTAL DELAY 4 0.0069
34 LIP EROSION 5 0.0068
35 OSMOTIC DEMYELINATION SYNDROME 5 0.0068
36 PULMONARY ALVEOLAR HAEMORRHAGE 38 0.0068
37 PALATAL OEDEMA 8 0.0065
38 MONOCYTOSIS 4 0.0064
39 TACHYARRHYTHMIA 16 0.0064
40 ANAL INFLAMMATION 4 0.0063
41 BLOOD IMMUNOGLOBULIN A DECREASED 4 0.0061
42 NEUROLOGICAL SYMPTOM 35 0.0061
43 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 101 0.0059
44 TYPE IV HYPERSENSITIVITY REACTION 16 0.0058
45 NODULE 76 0.0058
46 ACUTE SINUSITIS 10 0.0058
47 CLOSTRIDIUM COLITIS 7 0.0058
48 FOETAL DISTRESS SYNDROME 12 0.0057
49 MUCOSAL EROSION 5 0.0055
50 MYCOBACTERIUM CHELONAE INFECTION 4 0.0054
51 FAECES PALE 12 0.0054
52 INFUSION SITE DISCHARGE 9 0.0051
53 BILIARY TRACT DISORDER 7 0.0051
54 PROTHROMBIN TIME SHORTENED 7 0.0050
55 HEART VALVE REPLACEMENT 7 0.0047
56 ALLERGIC SINUSITIS 4 0.0047
57 LUNG HYPERINFLATION 4 0.0047
58 CHOLECYSTITIS CHRONIC 30 0.0045
59 PSEUDOMEMBRANOUS COLITIS 10 0.0045
60 CLOSTRIDIAL INFECTION 15 0.0044
61 OBSTRUCTIVE AIRWAYS DISORDER 48 0.0043
62 LEUKOCYTOCLASTIC VASCULITIS 7 0.0043
63 CHRONIC SINUSITIS 16 0.0043
64 INFUSION SITE BRUISING 9 0.0042
65 VASCULITIS 48 0.0041
66 JAUNDICE CHOLESTATIC 14 0.0040
67 SPUTUM DISCOLOURED 37 0.0039
68 CLOSTRIDIUM DIFFICILE COLITIS 39 0.0037
69 JAUNDICE 93 0.0035
70 TOXIC EPIDERMAL NECROLYSIS 52 0.0034
71 CHEST INJURY 7 0.0034
72 ENTEROCOLITIS HAEMORRHAGIC 5 0.0034
73 CYTOLYTIC HEPATITIS 11 0.0033
74 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 5 0.0033
75 RASH MORBILLIFORM 9 0.0032
76 TUBERCULIN TEST POSITIVE 8 0.0032
77 PRODUCTIVE COUGH 149 0.0031
78 IMMUNE RECONSTITUTION SYNDROME 4 0.0031
79 DERMATITIS EXFOLIATIVE 15 0.0030
80 RECTAL ABSCESS 5 0.0030
81 KLEBSIELLA INFECTION 15 0.0030
82 BILIARY DYSKINESIA 5 0.0029
83 CHOLANGITIS SCLEROSING 6 0.0029
84 MENINGITIS ASEPTIC 13 0.0029
85 SPUTUM INCREASED 6 0.0028
86 BILIARY COLIC 8 0.0027
87 CLOSTRIDIUM TEST POSITIVE 6 0.0027
88 BLOOD CULTURE POSITIVE 8 0.0027
89 STEVENS-JOHNSON SYNDROME 59 0.0027
90 HYPOPROTEINAEMIA 5 0.0026
91 ANGIONEUROTIC OEDEMA 7 0.0026
92 METASTATIC MALIGNANT MELANOMA 6 0.0026
93 PULMONARY FIBROSIS 50 0.0026
94 TYPE I HYPERSENSITIVITY 9 0.0026
95 CHOLESTASIS 49 0.0025
96 SKIN ODOUR ABNORMAL 10 0.0025
97 HYPOXIA 89 0.0025
98 WHEEZING 148 0.0025
99 HEPATITIS ACUTE 16 0.0025
100 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 8 0.0024
101 HYPOSPADIAS 5 0.0024
102 PURPURA 21 0.0024
103 HAEMORRHAGE URINARY TRACT 6 0.0024
104 EXPOSURE TO SARS-COV-2 4 0.0024
105 FIXED ERUPTION 4 0.0023
106 LYMPHOCYTOSIS 5 0.0023
107 CERVICAL SPINAL STENOSIS 4 0.0023
108 WOUND SECRETION 9 0.0023
109 RADICULOPATHY 6 0.0023
110 ACUTE HEPATIC FAILURE 31 0.0023
111 MIDDLE EAR EFFUSION 5 0.0023
112 VASCULAR DEVICE INFECTION 10 0.0022
113 ORTHOPNOEA 7 0.0022
114 RASH MACULO-PAPULAR 48 0.0022
115 LYMPH NODE PAIN 4 0.0021
116 BILIRUBIN CONJUGATED INCREASED 5 0.0021
117 NASAL OBSTRUCTION 4 0.0021
118 INFECTED SKIN ULCER 4 0.0021
119 PULMONARY INFARCTION 5 0.0021
120 LYMPHADENOPATHY MEDIASTINAL 4 0.0021
121 RENAL FAILURE ACUTE 88 0.0021
122 DRUG-INDUCED LIVER INJURY 65 0.0021
123 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 16 0.0021
124 BRONCHOPNEUMONIA 7 0.0020
125 VULVOVAGINAL MYCOTIC INFECTION 8 0.0020
126 HYPERAEMIA 4 0.0020
127 EMPYEMA 4 0.0020
128 ANORECTAL DISORDER 4 0.0020
129 BONE EROSION 7 0.0020
130 CHOLANGITIS 12 0.0019
131 BLOOD ALKALINE PHOSPHATASE INCREASED 48 0.0019
132 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 5 0.0019
133 HYPERSENSITIVITY VASCULITIS 5 0.0019
134 TOXIC SKIN ERUPTION 19 0.0019
135 CATHETER SITE ERYTHEMA 4 0.0019
136 HEPATIC NECROSIS 7 0.0019
137 JAW FRACTURE 4 0.0019
138 DEAFNESS NEUROSENSORY 6 0.0018
139 COLONOSCOPY 4 0.0018
140 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 87 0.0018
141 THERAPEUTIC AGENT TOXICITY 6 0.0018
142 HAEMOPTYSIS 50 0.0018
143 DISTRIBUTIVE SHOCK 4 0.0018
144 GAMMA-GLUTAMYLTRANSFERASE INCREASED 39 0.0018
145 OBESITY 28 0.0018
146 INFUSION SITE SWELLING 11 0.0017
147 CANDIDIASIS 7 0.0017
148 HAEMANGIOMA 4 0.0017
149 INTERNATIONAL NORMALISED RATIO DECREASED 7 0.0017
150 MENOPAUSAL SYMPTOMS 4 0.0017
151 ERYTHEMA MULTIFORME 16 0.0017
152 CHROMATURIA 38 0.0017
153 HUMERUS FRACTURE 8 0.0017
154 TUBULOINTERSTITIAL NEPHRITIS 31 0.0017
155 LIP OEDEMA 7 0.0017
156 LYMPHADENITIS 4 0.0017
157 ESCHERICHIA URINARY TRACT INFECTION 7 0.0016
158 HEPATITIS 42 0.0016
159 HYPERBILIRUBINAEMIA 17 0.0016
160 BREATH ODOUR 4 0.0016
161 LEFT VENTRICULAR HYPERTROPHY 7 0.0016
162 IRON DEFICIENCY ANAEMIA 15 0.0016
163 NASAL POLYPS 8 0.0016
164 BLOOD IMMUNOGLOBULIN G DECREASED 4 0.0016
165 OLIGURIA 10 0.0016
166 INFUSION SITE EXTRAVASATION 10 0.0016
167 BLOOD BILIRUBIN INCREASED 43 0.0016
168 ASTHMA 179 0.0016
169 BRAIN ABSCESS 4 0.0016
170 PRODUCT COLOUR ISSUE 8 0.0016
171 STUPOR 5 0.0016
172 LYMPHOCYTE COUNT INCREASED 5 0.0015
173 HEPATOMEGALY 15 0.0015
174 INFUSION SITE HAEMORRHAGE 5 0.0015
175 SYNOVIAL CYST 7 0.0015
176 MYCOBACTERIUM AVIUM COMPLEX INFECTION 4 0.0015
177 BLOOD SODIUM INCREASED 4 0.0015
178 ABDOMINAL RIGIDITY 4 0.0015
179 HIATUS HERNIA 19 0.0015
180 LIVER INJURY 36 0.0015
181 HYPOTHYROIDISM 46 0.0014
182 ERYTHEMA NODOSUM 5 0.0014
183 BRONCHIOLITIS 5 0.0014
184 BREATH SOUNDS ABNORMAL 7 0.0014
185 THROMBOTIC THROMBOCYTOPENIC PURPURA 5 0.0014
186 STAPHYLOCOCCAL SEPSIS 7 0.0014
187 CHOLECYSTITIS ACUTE 8 0.0014
188 HEPATOCELLULAR INJURY 20 0.0014
189 MULTIPLE ALLERGIES 11 0.0014
190 GALLBLADDER DISORDER 25 0.0014
191 ERYSIPELAS 7 0.0014
192 EMPHYSEMA 14 0.0014
193 ECONOMIC PROBLEM 21 0.0014
194 OCULAR ICTERUS 6 0.0014
195 ATRIOVENTRICULAR BLOCK FIRST DEGREE 6 0.0014
196 RALES 8 0.0014
197 TOOTH ABSCESS 14 0.0014
198 RASH PUSTULAR 10 0.0014
199 EOSINOPHILIA 24 0.0014
200 ORAL CANDIDIASIS 18 0.0014
201 ATELECTASIS 13 0.0013
202 TENDERNESS 14 0.0013
203 PULMONARY MASS 20 0.0013
204 SEASONAL ALLERGY 19 0.0013
205 TONSILLITIS 7 0.0013
206 LIVER FUNCTION TEST ABNORMAL 39 0.0013
207 HAEMOLYTIC ANAEMIA 12 0.0013
208 ANAPHYLACTIC REACTION 74 0.0013
209 INFUSION SITE REACTION 4 0.0013
210 SINUSITIS 137 0.0013
211 PULMONARY EMBOLISM 126 0.0013
212 PARANASAL SINUS DISCOMFORT 5 0.0013
213 DERMATITIS CONTACT 15 0.0013
214 TONGUE OEDEMA 5 0.0013
215 LUNG DISORDER 64 0.0013
216 ANAL ABSCESS 7 0.0013
217 FAECES DISCOLOURED 28 0.0013
218 YELLOW SKIN 6 0.0013
219 EPIGASTRIC DISCOMFORT 5 0.0013
220 DYSPNOEA EXERTIONAL 48 0.0013
221 STREPTOCOCCAL INFECTION 7 0.0013
222 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 32 0.0012
223 EAR INFECTION 33 0.0012
224 SKIN LESION 34 0.0012
225 GENERALISED ERYTHEMA 7 0.0012
226 GASTROINTESTINAL INFECTION 11 0.0012
227 TENDON DISORDER 8 0.0012
228 PSYCHIATRIC SYMPTOM 9 0.0012
229 BODY TEMPERATURE DECREASED 12 0.0012
230 ORGANISING PNEUMONIA 6 0.0012
231 PHARYNGITIS 15 0.0012
232 BRONCHOSPASM 17 0.0012
233 INFUSION SITE ERYTHEMA 10 0.0012
234 FACE OEDEMA 20 0.0012
235 DYSLIPIDAEMIA 6 0.0012
236 SINUS HEADACHE 7 0.0012
237 HEPATIC CYST 4 0.0012
238 ODYNOPHAGIA 7 0.0012
239 ALANINE AMINOTRANSFERASE INCREASED 72 0.0012
240 RENAL FAILURE CHRONIC 9 0.0012
241 UPPER RESPIRATORY TRACT INFECTION 54 0.0012
242 ECCHYMOSIS 8 0.0012
243 CACHEXIA 6 0.0012
244 HEPATIC FIBROSIS 4 0.0012
245 MYOPATHY 10 0.0012
246 INTERNATIONAL NORMALISED RATIO INCREASED 33 0.0012
247 MULTI-ORGAN FAILURE 20 0.0012
248 HORDEOLUM 5 0.0012
249 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 81 0.0011
250 LARYNGEAL OEDEMA 7 0.0011
251 BLOOD ALBUMIN DECREASED 9 0.0011
252 LUNG INFILTRATION 10 0.0011
253 PHYSICAL DISABILITY 5 0.0011
254 ASPARTATE AMINOTRANSFERASE INCREASED 60 0.0011
255 CHOLELITHIASIS 37 0.0011
256 HAEMORRHAGE SUBCUTANEOUS 4 0.0011
257 DIVERTICULUM 8 0.0011
258 ANAL FISSURE 6 0.0011
259 SECRETION DISCHARGE 14 0.0011
260 RHINITIS 9 0.0011
261 MONOCYTE COUNT INCREASED 4 0.0011
262 PATHOGEN RESISTANCE 10 0.0011
263 GASTROENTERITIS 16 0.0011
264 CUTANEOUS VASCULITIS 4 0.0011
265 PROCTALGIA 7 0.0011
266 DRUG LEVEL BELOW THERAPEUTIC 6 0.0011
267 BLOOD PRESSURE DIASTOLIC INCREASED 5 0.0011
268 THROMBOSIS 87 0.0011
269 BRONCHITIS 80 0.0011
270 LOCALISED OEDEMA 5 0.0011
271 AGRANULOCYTOSIS 20 0.0011
272 BURSITIS 13 0.0011
273 PULMONARY CONGESTION 14 0.0011
274 SINUS DISORDER 21 0.0011
275 SCAR 18 0.0011
276 ANAPHYLACTIC SHOCK 27 0.0010
277 CLAVICLE FRACTURE 4 0.0010
278 WRONG PRODUCT ADMINISTERED 7 0.0010
279 HEPATOTOXICITY 23 0.0010
280 DECREASED ACTIVITY 11 0.0010
281 DIVERTICULITIS 28 0.0010
282 BLOOD LACTATE DEHYDROGENASE INCREASED 16 0.0010
283 INFUSION SITE PAIN 13 0.0010
284 INFLAMMATORY MARKER INCREASED 5 0.0010
285 CLOSTRIDIUM DIFFICILE INFECTION 22 0.0010
286 APHONIA 14 0.0010
287 PROTEIN URINE PRESENT 5 0.0010
288 GASTROINTESTINAL PAIN 11 0.0010
289 CORONARY ARTERY STENOSIS 5 0.0010
290 PAPULE 7 0.0010
291 PHARYNGEAL OEDEMA 15 0.0010
292 HYPERURICAEMIA 4 0.0010
293 UPPER-AIRWAY COUGH SYNDROME 8 0.0010
294 QUALITY OF LIFE DECREASED 13 0.0010
295 HEPATIC STEATOSIS 18 0.0010
296 RESPIRATORY TRACT INFECTION 25 0.0010
297 PETECHIAE 10 0.0010
298 PRODUCT ODOUR ABNORMAL 10 0.0010
299 EYELID OEDEMA 11 0.0009
300 HYPERPYREXIA 4 0.0009
301 LUNG NEOPLASM 4 0.0009
302 C-REACTIVE PROTEIN ABNORMAL 6 0.0009
303 HYDRONEPHROSIS 7 0.0009
304 HYPERCHOLESTEROLAEMIA 9 0.0009
305 ANGIOEDEMA 41 0.0009
306 PRURITUS GENERALISED 20 0.0009
307 CHEILITIS 5 0.0009
308 PYELONEPHRITIS 8 0.0009
309 ANGINA UNSTABLE 6 0.0009
310 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 5 0.0009
311 SPINAL OSTEOARTHRITIS 8 0.0009
312 TOOTH INFECTION 12 0.0009
313 ABDOMINAL ABSCESS 4 0.0009
314 LOWER RESPIRATORY TRACT INFECTION 41 0.0009
315 LUNG INFECTION 14 0.0009
316 INTRACRANIAL PRESSURE INCREASED 5 0.0009
317 ANGIOPATHY 5 0.0009
318 FISTULA 10 0.0009
319 SINUS CONGESTION 12 0.0009
320 CIRCULATORY COLLAPSE 15 0.0009
321 BLOOD THYROID STIMULATING HORMONE DECREASED 4 0.0009
322 BLOOD PRESSURE SYSTOLIC DECREASED 4 0.0009
323 NEUTROPHIL COUNT INCREASED 9 0.0009
324 HIDRADENITIS 8 0.0009
325 FUNGAL INFECTION 29 0.0009
326 LYMPHOEDEMA 6 0.0009
327 CARPAL TUNNEL SYNDROME 12 0.0009
328 DRUG DISPENSING ERROR 13 0.0008
329 URINE ODOUR ABNORMAL 5 0.0008
330 RASH GENERALISED 22 0.0008
331 VENTRICULAR TACHYCARDIA 14 0.0008
332 RETINAL HAEMORRHAGE 6 0.0008
333 NEUTROPENIC SEPSIS 6 0.0008
334 EOSINOPHIL COUNT INCREASED 7 0.0008
335 BLOOD UREA INCREASED 14 0.0008
336 PROTHROMBIN TIME PROLONGED 5 0.0008
337 HYPOVOLAEMIC SHOCK 4 0.0008
338 HAEMODIALYSIS 7 0.0008
339 RESPIRATORY DISTRESS 23 0.0008
340 DERMATITIS BULLOUS 6 0.0008
341 SQUAMOUS CELL CARCINOMA OF SKIN 5 0.0008
342 ENTEROCOCCAL INFECTION 4 0.0008
343 FAECES SOFT 6 0.0008
344 DRUG RESISTANCE 21 0.0008
345 KIDNEY INFECTION 16 0.0008
346 ANURIA 7 0.0008
347 MENISCUS INJURY 5 0.0008
348 OROPHARYNGEAL PAIN 75 0.0008
349 LIGAMENT SPRAIN 8 0.0008
350 MUCOSAL INFLAMMATION 21 0.0008
351 URINE OUTPUT DECREASED 7 0.0008
352 OVARIAN CYST 8 0.0008
353 DERMATITIS ALLERGIC 10 0.0008
354 PRODUCT ADMINISTRATION ERROR 16 0.0008
355 TROPONIN INCREASED 6 0.0008
356 STAPHYLOCOCCAL INFECTION 26 0.0008
357 ACIDOSIS 6 0.0008
358 FACIAL PAIN 7 0.0008
359 BOWEL MOVEMENT IRREGULARITY 6 0.0008
360 MATERNAL DRUGS AFFECTING FOETUS 6 0.0008
361 ENDOCARDITIS 4 0.0008
362 EAR DISCOMFORT 8 0.0008
363 CEREBRAL ISCHAEMIA 4 0.0008
364 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
365 APHTHOUS ULCER 6 0.0008
366 POOR VENOUS ACCESS 8 0.0008
367 C-REACTIVE PROTEIN INCREASED 28 0.0008
368 BLOOD PRESSURE SYSTOLIC INCREASED 15 0.0008
369 RESPIRATORY DISORDER 23 0.0008
370 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
371 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
372 CYANOSIS 12 0.0008
373 HEPATIC FAILURE 23 0.0008
374 IMMUNE SYSTEM DISORDER 10 0.0008
375 PNEUMOTHORAX 12 0.0008
376 CONJUNCTIVITIS 14 0.0008
377 HYPERLIPIDAEMIA 9 0.0008
378 CHEST DISCOMFORT 77 0.0008
379 EATING DISORDER 16 0.0008
380 VIRAL INFECTION 25 0.0008
381 HEPATIC ENCEPHALOPATHY 7 0.0007
382 HYPOPHAGIA 19 0.0007
383 PYREXIA 257 0.0007
384 BRONCHIECTASIS 5 0.0007
385 FREQUENT BOWEL MOVEMENTS 20 0.0007
386 POSTOPERATIVE WOUND INFECTION 5 0.0007
387 LIMB INJURY 20 0.0007
388 TACHYPNOEA 10 0.0007
389 ACUTE RESPIRATORY DISTRESS SYNDROME 13 0.0007
390 EYE INFLAMMATION 7 0.0007
391 POLYURIA 6 0.0007
392 JAW DISORDER 4 0.0007
393 ESCHERICHIA INFECTION 6 0.0007
394 NEPHROTIC SYNDROME 5 0.0007
395 INTESTINAL ISCHAEMIA 4 0.0007
396 ANHEDONIA 19 0.0007
397 EMBOLISM 6 0.0007
398 EAR PAIN 14 0.0007
399 TRANSAMINASES INCREASED 16 0.0007
400 INSURANCE ISSUE 11 0.0007
401 OEDEMA 39 0.0007
402 HYPERTRANSAMINASAEMIA 5 0.0007
403 ACUTE PULMONARY OEDEMA 4 0.0007
404 STATUS EPILEPTICUS 8 0.0007
405 PSEUDOMONAS INFECTION 6 0.0007
406 PNEUMONIA 226 0.0007
407 INFLAMMATION 36 0.0007
408 RHINORRHOEA 45 0.0007
409 FEBRILE NEUTROPENIA 46 0.0007
410 ENTEROCOLITIS 4 0.0007
411 PLATELET COUNT INCREASED 9 0.0007
412 RASH ERYTHEMATOUS 33 0.0007
413 SCIATICA 11 0.0007
414 ABSCESS 11 0.0007
415 BODY TEMPERATURE INCREASED 14 0.0007
416 RESPIRATORY FAILURE 50 0.0007
417 HYPOVOLAEMIA 4 0.0007
418 ORAL DISORDER 5 0.0007
419 MOUTH HAEMORRHAGE 5 0.0007
420 SARS-COV-2 TEST POSITIVE 9 0.0007
421 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
422 HYPOPHOSPHATAEMIA 5 0.0007
423 ARTHROPOD BITE 5 0.0007
424 BLOOD IRON DECREASED 8 0.0007
425 DRUG INTOLERANCE 65 0.0007
426 HAEMATURIA 23 0.0007
427 CHOLECYSTITIS 8 0.0007
428 COUGH 187 0.0007
429 TOOTHACHE 12 0.0007
430 OSTEOARTHRITIS 28 0.0007
431 RENAL PAIN 7 0.0007
432 IMPAIRED GASTRIC EMPTYING 9 0.0007
433 BLOOD CREATINE PHOSPHOKINASE INCREASED 19 0.0007
434 ABDOMINAL PAIN 153 0.0007
435 OEDEMA PERIPHERAL 80 0.0007
436 HAEMODYNAMIC INSTABILITY 5 0.0007
437 PERIPHERAL COLDNESS 9 0.0007
438 HYPERTHERMIA 5 0.0007
439 SEPSIS 73 0.0007
440 INJURY 46 0.0007
441 LIVER DISORDER 29 0.0007
442 SKIN EXFOLIATION 55 0.0007
443 WHITE BLOOD CELL COUNT INCREASED 25 0.0007
444 CANDIDA INFECTION 11 0.0007
445 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
446 SKIN LACERATION 7 0.0006
447 DEFORMITY 6 0.0006
448 DIARRHOEA HAEMORRHAGIC 6 0.0006
449 FLANK PAIN 6 0.0006
450 DISSEMINATED INTRAVASCULAR COAGULATION 9 0.0006
451 MULTIPLE INJURIES 4 0.0006
452 PROTEINURIA 12 0.0006
453 DRUG INTERACTION 100 0.0006
454 VENTRICULAR FIBRILLATION 7 0.0006
455 TRICUSPID VALVE INCOMPETENCE 5 0.0006
456 HYPERTENSIVE CRISIS 7 0.0006
457 DYSPNOEA 356 0.0006
458 RASH PRURITIC 34 0.0006
459 OXYGEN SATURATION DECREASED 35 0.0006
460 LOCALISED INFECTION 15 0.0006
461 FLUID OVERLOAD 9 0.0006
462 HAEMATOMA 16 0.0006
463 HERPES SIMPLEX 4 0.0006
464 DRUG SPECIFIC ANTIBODY PRESENT 4 0.0006
465 POST PROCEDURAL INFECTION 5 0.0006
466 SHOCK HAEMORRHAGIC 5 0.0006
467 DECUBITUS ULCER 5 0.0006
468 CHOLECYSTECTOMY 7 0.0006
469 GASTROENTERITIS VIRAL 11 0.0006
470 SLEEP DISORDER 43 0.0006
471 SHOCK 14 0.0006
472 CARDIAC FAILURE ACUTE 4 0.0006
473 URINARY TRACT INFECTION 102 0.0006
474 LIVE BIRTH 5 0.0006
475 SPLENOMEGALY 7 0.0006
476 BLOOD CREATININE INCREASED 39 0.0006
477 ATRIAL FIBRILLATION 58 0.0006
478 CELLULITIS 30 0.0006
479 CONDITION AGGRAVATED 181 0.0006
480 FEAR 16 0.0006
481 LYMPHADENOPATHY 21 0.0006
482 MELAENA 13 0.0006
483 PANCYTOPENIA 33 0.0006
484 HEMIPARESIS 10 0.0006
485 NEUROLEPTIC MALIGNANT SYNDROME 7 0.0006
486 BACTERAEMIA 7 0.0006
487 BACTERIAL INFECTION 11 0.0006
488 MOTOR DYSFUNCTION 6 0.0006
489 DRUG EXPOSURE DURING PREGNANCY 20 0.0006
490 PNEUMONITIS 16 0.0006
491 PRURITUS 225 0.0006
492 EYE MOVEMENT DISORDER 4 0.0006
493 CROHN'S DISEASE 4 0.0006
494 JOINT EFFUSION 4 0.0006
495 BLOOD URINE PRESENT 11 0.0006
496 BLOOD MAGNESIUM DECREASED 5 0.0006
497 PSYCHOLOGICAL TRAUMA 5 0.0006
498 ENCEPHALITIS 4 0.0006
499 RHABDOMYOLYSIS 24 0.0006
500 BRAIN FOG 9 0.0006
501 DERMATITIS 12 0.0006
502 HEPATIC ENZYME INCREASED 39 0.0006
503 ACUTE RESPIRATORY FAILURE 11 0.0006
504 PRODUCT USE COMPLAINT 9 0.0006
505 GLOMERULAR FILTRATION RATE DECREASED 7 0.0006
506 CARDIOMEGALY 7 0.0006
507 HYPERCALCAEMIA 7 0.0006
508 ABASIA 14 0.0006
509 LYMPHOPENIA 8 0.0006
510 DRUG ERUPTION 10 0.0006
511 URTICARIA 94 0.0006
512 WRONG DRUG ADMINISTERED 5 0.0006
513 FEAR OF INJECTION 4 0.0006
514 DIARRHOEA 359 0.0006
515 MUSCLE TIGHTNESS 9 0.0006
516 HAEMATOCRIT DECREASED 11 0.0006
517 PHARYNGITIS STREPTOCOCCAL 6 0.0006
518 BRAIN OEDEMA 7 0.0006
519 BLOOD PRESSURE ABNORMAL 11 0.0006
520 INFECTION 80 0.0006
521 DEHYDRATION 73 0.0005
522 PRODUCT PHYSICAL ISSUE 11 0.0005
523 ROTATOR CUFF SYNDROME 7 0.0005
524 NASAL CONGESTION 32 0.0005
525 ANOREXIA 7 0.0005
526 GRAND MAL CONVULSION 5 0.0005
527 PRODUCT DISTRIBUTION ISSUE 5 0.0005
528 DIPLOPIA 14 0.0005
529 DEEP VEIN THROMBOSIS 35 0.0005
530 HEPATIC FUNCTION ABNORMAL 20 0.0005
531 RASH PAPULAR 12 0.0005
532 NEPHROPATHY TOXIC 6 0.0005
533 BLOOD CALCIUM DECREASED 6 0.0005
534 PHOTOPHOBIA 10 0.0005
535 LACERATION 5 0.0005
536 TACHYCARDIA 47 0.0005
537 BLOOD COUNT ABNORMAL 8 0.0005
538 HYPOTENSION 105 0.0005
539 HERPES ZOSTER 30 0.0005
540 CHILLS 61 0.0005
541 DIFFUSE LARGE B-CELL LYMPHOMA 4 0.0005
542 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 27 0.0005
543 SINUS BRADYCARDIA 5 0.0005
544 PRODUCT TASTE ABNORMAL 7 0.0005
545 CONGENITAL ANOMALY 4 0.0005
546 TENDONITIS 8 0.0005
547 HAEMOGLOBIN DECREASED 53 0.0005
548 HYPOALBUMINAEMIA 4 0.0005
549 HAEMORRHOIDS 10 0.0005
550 LYMPHOCYTE COUNT DECREASED 9 0.0005
551 RASH 221 0.0005
552 MYOCLONUS 6 0.0005
553 GOUT 9 0.0005
554 ATRIAL FLUTTER 4 0.0005
555 SYNOVITIS 9 0.0005
556 DYSPHAGIA 47 0.0005
557 GASTRITIS 13 0.0005
558 BONE DISORDER 9 0.0005
559 INFLUENZA 55 0.0005
560 BLOOD POTASSIUM INCREASED 8 0.0005
561 BACK DISORDER 8 0.0005
562 ANXIETY 140 0.0005
563 ERYTHEMA 101 0.0005
564 RESPIRATORY DEPRESSION 6 0.0005
565 PANCREATITIS ACUTE 11 0.0005
566 DYSURIA 18 0.0005
567 ABNORMAL FAECES 4 0.0005
568 HICCUPS 4 0.0005
569 EYE DISORDER 16 0.0005
570 TENDON RUPTURE 6 0.0005
571 CHEST PAIN 90 0.0005
572 TEMPERATURE INTOLERANCE 5 0.0005
573 ANOSMIA 7 0.0005
574 ACUTE CORONARY SYNDROME 4 0.0005
575 TOOTH LOSS 10 0.0005
576 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
577 HEMIPLEGIA 4 0.0005
578 THROAT TIGHTNESS 13 0.0005
579 COAGULOPATHY 8 0.0005
580 PULMONARY HYPERTENSION 10 0.0005
581 LEUKOPENIA 24 0.0005
582 ABDOMINAL DISTENSION 50 0.0005
583 TINNITUS 22 0.0005
584 CONTUSION 46 0.0005
585 GENERAL PHYSICAL HEALTH DETERIORATION 55 0.0005
586 MOUTH ULCERATION 10 0.0005
587 ABDOMINAL PAIN LOWER 12 0.0005
588 JOINT DISLOCATION 5 0.0005
589 CONVULSION 27 0.0005
590 HAEMATOCHEZIA 26 0.0005
591 FACIAL PARALYSIS 4 0.0005
592 PULMONARY OEDEMA 21 0.0005
593 POST PROCEDURAL COMPLICATION 9 0.0005
594 HERNIA 9 0.0005
595 MUSCULOSKELETAL DISCOMFORT 8 0.0005
596 PARANOIA 8 0.0005
597 MUSCLE STRAIN 4 0.0005
598 CHRONIC KIDNEY DISEASE 35 0.0005
599 GASTROOESOPHAGEAL REFLUX DISEASE 37 0.0005
600 ORTHOSTATIC HYPOTENSION 8 0.0005
601 PULMONARY THROMBOSIS 5 0.0005
602 MUSCULOSKELETAL PAIN 24 0.0005
603 RASH MACULAR 16 0.0005
604 INTERVERTEBRAL DISC PROTRUSION 10 0.0005
605 JOINT STIFFNESS 12 0.0005
606 BEDRIDDEN 6 0.0005
607 BLOOD CALCIUM INCREASED 4 0.0005
608 JOINT SWELLING 55 0.0005
609 GROIN PAIN 4 0.0005
610 DEVICE RELATED INFECTION 7 0.0005
611 COLD SWEAT 8 0.0005
612 UPPER LIMB FRACTURE 9 0.0005
613 RENAL DISORDER 21 0.0005
614 SWOLLEN TONGUE 14 0.0004
615 HYPERSENSITIVITY 83 0.0004
616 TREATMENT FAILURE 37 0.0004
617 SKIN INFECTION 5 0.0004
618 BLISTER 25 0.0004
619 RENAL FAILURE 59 0.0004
620 ASTHENIA 167 0.0004
621 VOMITING 208 0.0004
622 OSTEOMYELITIS 8 0.0004
623 PAIN IN EXTREMITY 130 0.0004
624 PALLOR 12 0.0004
625 RESPIRATORY TRACT CONGESTION 7 0.0004
626 CYSTITIS 14 0.0004
627 MOOD SWINGS 14 0.0004
628 END STAGE RENAL DISEASE 8 0.0004
629 THROMBOCYTOPENIA 49 0.0004
630 EXOSTOSIS 4 0.0004
631 ABDOMINAL PAIN UPPER 90 0.0004
632 MENTAL DISORDER 19 0.0004
633 PANCREATITIS 23 0.0004
634 INCREASED TENDENCY TO BRUISE 4 0.0004
635 ABNORMAL DREAMS 12 0.0004
636 LETHARGY 25 0.0004
637 HAEMATEMESIS 11 0.0004
638 HYPOKALAEMIA 20 0.0004
639 INTERVERTEBRAL DISC DEGENERATION 4 0.0004
640 APHASIA 13 0.0004
641 CAESAREAN SECTION 5 0.0004
642 NEPHROPATHY 4 0.0004
643 ILLNESS 44 0.0004
644 HEPATIC CIRRHOSIS 8 0.0004
645 SKIN ULCER 11 0.0004
646 ABORTION INDUCED 4 0.0004
647 ABORTION SPONTANEOUS 17 0.0004
648 CARDIAC ARREST 35 0.0004
649 COVID-19 PNEUMONIA 5 0.0004
650 DRUG LEVEL INCREASED 7 0.0004
651 ATAXIA 5 0.0004
652 CYTOMEGALOVIRUS INFECTION 7 0.0004
653 SLEEP APNOEA SYNDROME 8 0.0004
654 PARALYSIS 6 0.0004
655 POOR QUALITY SLEEP 9 0.0004
656 POLYNEUROPATHY 5 0.0004
657 IMPAIRED QUALITY OF LIFE 6 0.0004
658 BRADYCARDIA 22 0.0004
659 EPISTAXIS 31 0.0004
660 SEPTIC SHOCK 18 0.0004
661 PRODUCT DISPENSING ERROR 9 0.0004
662 GASTROINTESTINAL DISORDER 37 0.0004
663 NOCTURIA 5 0.0004
664 HEAD INJURY 13 0.0004
665 CHOKING 8 0.0004
666 SYNCOPE 41 0.0004
667 CONFUSIONAL STATE 66 0.0004
668 HYPONATRAEMIA 23 0.0004
669 ENCEPHALOPATHY 10 0.0004
670 METABOLIC ACIDOSIS 13 0.0004
671 ACUTE KIDNEY INJURY 62 0.0004
672 DISABILITY 8 0.0004
673 HYPOAESTHESIA ORAL 6 0.0004
674 MEDICATION ERROR 22 0.0004
675 FEEDING DISORDER 8 0.0004
676 NECK PAIN 22 0.0004
677 LIP SWELLING 13 0.0004
678 ELECTROCARDIOGRAM QT PROLONGED 14 0.0004
679 RIB FRACTURE 8 0.0004
680 LEUKOCYTOSIS 7 0.0004
681 DYSPEPSIA 38 0.0004
682 PELVIC PAIN 7 0.0004
683 ACUTE MYELOID LEUKAEMIA 6 0.0004
684 ANAEMIA 73 0.0004
685 EMOTIONAL DISTRESS 46 0.0004
686 BACK PAIN 88 0.0004
687 PLEURAL EFFUSION 23 0.0004
688 ADVERSE REACTION 5 0.0004
689 EYE SWELLING 14 0.0004
690 GAIT DISTURBANCE 72 0.0004
691 DYSPHONIA 22 0.0004
692 BLOOD PRESSURE FLUCTUATION 9 0.0004
693 IMPAIRED WORK ABILITY 8 0.0004
694 MALAISE 164 0.0004
695 JOINT RANGE OF MOTION DECREASED 5 0.0004
696 LABORATORY TEST ABNORMAL 11 0.0004
697 WEIGHT DECREASED 104 0.0004
698 DYSARTHRIA 14 0.0004
699 HYPERKALAEMIA 13 0.0004
700 NEPHROLITHIASIS 17 0.0004
701 FLATULENCE 21 0.0004
702 DECREASED APPETITE 86 0.0004
703 SWELLING FACE 24 0.0004
704 DRUG TOXICITY 5 0.0004
705 MIGRAINE 35 0.0004
706 SYSTEMIC LUPUS ERYTHEMATOSUS 13 0.0004
707 GINGIVAL BLEEDING 5 0.0004
708 IRRITABILITY 22 0.0004
709 ASPIRATION 4 0.0004
710 COGNITIVE DISORDER 17 0.0004
711 ABDOMINAL DISCOMFORT 61 0.0004
712 CONTRAINDICATED PRODUCT ADMINISTERED 11 0.0004
713 PROSTATIC SPECIFIC ANTIGEN INCREASED 5 0.0004
714 CARDIAC FAILURE 29 0.0004
715 MENTAL STATUS CHANGES 10 0.0004
716 ORAL DISCOMFORT 5 0.0004
717 SKIN DISORDER 12 0.0004
718 NASOPHARYNGITIS 66 0.0004
719 MASS 5 0.0004
720 MALNUTRITION 4 0.0004
721 BURNING SENSATION 25 0.0004
722 INTESTINAL PERFORATION 4 0.0004
723 DEVICE OCCLUSION 5 0.0004
724 SKIN REACTION 5 0.0004
725 HEART RATE IRREGULAR 8 0.0004
726 DEPRESSED LEVEL OF CONSCIOUSNESS 14 0.0004
727 MITRAL VALVE INCOMPETENCE 4 0.0004
728 HEART RATE INCREASED 35 0.0004
729 RHEUMATOID ARTHRITIS 40 0.0004
730 INTERSTITIAL LUNG DISEASE 17 0.0004
731 RED BLOOD CELL COUNT DECREASED 10 0.0003
732 SUBDURAL HAEMATOMA 5 0.0003
733 ANGINA PECTORIS 10 0.0003
734 UNRESPONSIVE TO STIMULI 9 0.0003
735 CARDIOGENIC SHOCK 5 0.0003
736 PAIN 214 0.0003
737 INFUSION RELATED REACTION 23 0.0003
738 PARAESTHESIA ORAL 5 0.0003
739 BLOOD PRESSURE DECREASED 23 0.0003
740 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
741 ECZEMA 18 0.0003
742 NEUROTOXICITY 6 0.0003
743 COVID-19 60 0.0003
744 PALPITATIONS 40 0.0003
745 BLOOD TRIGLYCERIDES INCREASED 6 0.0003
746 ACUTE MYOCARDIAL INFARCTION 10 0.0003
747 HEAD DISCOMFORT 6 0.0003
748 DIABETES MELLITUS INADEQUATE CONTROL 6 0.0003
749 NEUTROPENIA 46 0.0003
750 ARRHYTHMIA 16 0.0003
751 DISEASE RECURRENCE 16 0.0003
752 RENAL IMPAIRMENT 28 0.0003
753 HALLUCINATION, VISUAL 7 0.0003
754 HEPATITIS C 4 0.0003
755 OSTEOPENIA 5 0.0003
756 HYPERGLYCAEMIA 12 0.0003
757 PRESYNCOPE 8 0.0003
758 DISORIENTATION 13 0.0003
759 INFLUENZA LIKE ILLNESS 27 0.0003
760 LOSS OF CONSCIOUSNESS 42 0.0003
761 FEELING HOT 20 0.0003
762 NEUROPATHY PERIPHERAL 31 0.0003
763 DEPRESSION 74 0.0003
764 EMOTIONAL DISORDER 10 0.0003
765 MYALGIA 55 0.0003
766 OSTEONECROSIS OF JAW 8 0.0003
767 LIMB DISCOMFORT 10 0.0003
768 DYSGEUSIA 24 0.0003
769 ILEUS 4 0.0003
770 BLOOD CHOLESTEROL INCREASED 15 0.0003
771 CONSTIPATION 70 0.0003
772 AGEUSIA 8 0.0003
773 DRY MOUTH 26 0.0003
774 PNEUMONIA ASPIRATION 8 0.0003
775 HALLUCINATION 24 0.0003
776 NEOPLASM PROGRESSION 11 0.0003
777 GASTRIC ULCER 6 0.0003
778 FEELING JITTERY 6 0.0003
779 ULCER 5 0.0003
780 HEADACHE 197 0.0003
781 SEROTONIN SYNDROME 6 0.0003
782 SNEEZING 7 0.0003
783 CARDIO-RESPIRATORY ARREST 13 0.0003
784 SWELLING 29 0.0003
785 DYSSTASIA 9 0.0003
786 ARTHRALGIA 128 0.0003
787 FATIGUE 238 0.0003
788 SPEECH DISORDER 16 0.0003
789 SKIN DISCOLOURATION 14 0.0003
790 NAUSEA 241 0.0003
791 WHITE BLOOD CELL COUNT DECREASED 33 0.0003
792 INSOMNIA 81 0.0003
793 ANKYLOSING SPONDYLITIS 4 0.0003
794 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
795 DIZZINESS 151 0.0003
796 CRYING 11 0.0003
797 EYE PAIN 17 0.0003
798 PLATELET COUNT DECREASED 32 0.0003
799 MUSCULAR WEAKNESS 34 0.0003
800 PERIPHERAL SWELLING 46 0.0003
801 TRANSIENT ISCHAEMIC ATTACK 10 0.0003
802 HYPOAESTHESIA 44 0.0003
803 DRUG ADMINISTRATION ERROR 9 0.0003
804 HYPERTENSION 62 0.0003
805 ARTHRITIS 23 0.0003
806 PRODUCT DOSE OMISSION 19 0.0003
807 COLITIS 11 0.0003
808 THROAT IRRITATION 13 0.0003
809 FIBROMYALGIA 7 0.0003
810 BLOOD PRESSURE INCREASED 44 0.0003
811 POLLAKIURIA 12 0.0003
812 HYPERHIDROSIS 37 0.0003
813 COORDINATION ABNORMAL 4 0.0003
814 WOUND 8 0.0003
815 PARAESTHESIA 45 0.0003
816 MUSCULOSKELETAL STIFFNESS 25 0.0003
817 HEART RATE DECREASED 10 0.0003
818 MULTIPLE ORGAN DYSFUNCTION SYNDROME 8 0.0003
819 STOMATITIS 17 0.0003
820 CEREBRAL HAEMORRHAGE 10 0.0003
821 LACTIC ACIDOSIS 9 0.0003
822 BALANCE DISORDER 24 0.0003
823 HYPERTHYROIDISM 4 0.0003
824 APATHY 4 0.0003
825 PRODUCT QUALITY ISSUE 37 0.0003
826 BLOOD GLUCOSE ABNORMAL 5 0.0003
827 URINARY RETENTION 9 0.0003
828 GAIT INABILITY 9 0.0003
829 NERVOUSNESS 14 0.0003
830 MIDDLE INSOMNIA 5 0.0003
831 HAEMORRHAGE INTRACRANIAL 4 0.0003
832 THERAPY NON-RESPONDER 12 0.0003
833 BLOOD POTASSIUM DECREASED 8 0.0003
834 BLOOD SODIUM DECREASED 5 0.0003
835 SUICIDAL IDEATION 24 0.0003
836 MUSCLE SPASMS 48 0.0003
837 PERICARDIAL EFFUSION 6 0.0003
838 MUSCULOSKELETAL CHEST PAIN 4 0.0003
839 EXPOSURE DURING PREGNANCY 16 0.0003
840 BASAL CELL CARCINOMA 4 0.0003
841 SKIN FISSURES 5 0.0003
842 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 14 0.0003
843 ABNORMAL BEHAVIOUR 10 0.0003
844 PROCEDURAL PAIN 7 0.0003
845 HOT FLUSH 19 0.0003
846 CATARACT 15 0.0003
847 HALLUCINATION, AUDITORY 4 0.0003
848 FEELING COLD 7 0.0003
849 PRODUCT STORAGE ERROR 22 0.0003
850 MOBILITY DECREASED 18 0.0003
851 NIGHT SWEATS 8 0.0002
852 HYPOGLYCAEMIA 12 0.0002
853 PAIN IN JAW 7 0.0002
854 PSORIATIC ARTHROPATHY 10 0.0002
855 VERTIGO 15 0.0002
856 BONE MARROW FAILURE 5 0.0002
857 DISCOMFORT 15 0.0002
858 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 44 0.0002
859 METASTASES TO BONE 4 0.0002
860 MANIA 4 0.0002
861 OSTEOPOROSIS 10 0.0002
862 DISTURBANCE IN ATTENTION 13 0.0002
863 PSYCHOTIC DISORDER 7 0.0002
864 METRORRHAGIA 4 0.0002
865 RETCHING 5 0.0002
866 JOINT INJURY 5 0.0002
867 LIVER FUNCTION TEST INCREASED 5 0.0002
868 RECTAL HAEMORRHAGE 10 0.0002
869 PHARMACEUTICAL PRODUCT COMPLAINT 6 0.0002
870 COMA 11 0.0002
871 DEAFNESS 6 0.0002
872 LOCAL SWELLING 4 0.0002
873 MYOCARDIAL INFARCTION 40 0.0002
874 SOMNOLENCE 46 0.0002
875 FALL 76 0.0002
876 DISEASE PROGRESSION 27 0.0002
877 HOSPITALISATION 35 0.0002
878 UNEVALUABLE EVENT 17 0.0002
879 CEREBROVASCULAR ACCIDENT 38 0.0002
880 NERVOUS SYSTEM DISORDER 7 0.0002
881 ISCHAEMIC STROKE 4 0.0002
882 CARDIAC FAILURE CONGESTIVE 18 0.0002
883 NEUTROPHIL COUNT DECREASED 9 0.0002
884 PANIC ATTACK 8 0.0002
885 WEIGHT INCREASED 49 0.0002
886 MOVEMENT DISORDER 7 0.0002
887 AGITATION 16 0.0002
888 AMNESIA 14 0.0002
889 SUICIDE ATTEMPT 13 0.0002
890 THERAPY CESSATION 11 0.0002
891 IMPAIRED HEALING 7 0.0002
892 HYPOCALCAEMIA 4 0.0002
893 FOOT FRACTURE 4 0.0002
894 TREMOR 35 0.0002
895 DRY SKIN 28 0.0002
896 NEOPLASM MALIGNANT 14 0.0002
897 FOETAL EXPOSURE DURING PREGNANCY 17 0.0002
898 FEELING ABNORMAL 50 0.0002
899 LOWER LIMB FRACTURE 4 0.0002
900 DEPRESSED MOOD 11 0.0002
901 GLAUCOMA 4 0.0002
902 NEEDLE ISSUE 6 0.0002
903 INTENTIONAL PRODUCT USE ISSUE 18 0.0002
904 MATERNAL EXPOSURE DURING PREGNANCY 18 0.0002
905 EXTRAPYRAMIDAL DISORDER 5 0.0002
906 CORONARY ARTERY DISEASE 6 0.0002
907 VISION BLURRED 27 0.0002
908 LUNG NEOPLASM MALIGNANT 8 0.0002
909 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
910 ACCIDENTAL OVERDOSE 7 0.0002
911 HAEMORRHAGE 20 0.0002
912 RESTLESSNESS 7 0.0002
913 ROAD TRAFFIC ACCIDENT 8 0.0002
914 WITHDRAWAL SYNDROME 8 0.0002
915 SURGERY 11 0.0002
916 INTENTIONAL OVERDOSE 12 0.0002
917 IRRITABLE BOWEL SYNDROME 4 0.0002
918 DRUG INEFFECTIVE 245 0.0002
919 HYPOACUSIS 8 0.0002
920 INTESTINAL OBSTRUCTION 7 0.0002
921 VAGINAL HAEMORRHAGE 8 0.0002
922 TREATMENT NONCOMPLIANCE 10 0.0002
923 CARDIAC DISORDER 17 0.0002
924 THERAPEUTIC RESPONSE DECREASED 11 0.0002
925 THERAPEUTIC RESPONSE SHORTENED 6 0.0002
926 VISUAL ACUITY REDUCED 6 0.0002
927 GASTROINTESTINAL HAEMORRHAGE 15 0.0002
928 COLITIS ULCERATIVE 8 0.0002
929 INCORRECT DRUG ADMINISTRATION DURATION 5 0.0002
930 INTENTIONAL DOSE OMISSION 5 0.0002
931 MEMORY IMPAIRMENT 24 0.0002
932 DELIRIUM 6 0.0002
933 BLINDNESS 7 0.0002
934 PRODUCT USE IN UNAPPROVED INDICATION 42 0.0002
935 URINARY INCONTINENCE 5 0.0002
936 ADVERSE DRUG REACTION 15 0.0002
937 PRODUCT DOSE OMISSION ISSUE 49 0.0002
938 PREMATURE BABY 5 0.0002
939 MENTAL IMPAIRMENT 4 0.0002
940 OFF LABEL USE 144 0.0002
941 EPILEPSY 5 0.0002
942 INJECTION SITE MASS 6 0.0002
943 DRY EYE 8 0.0002
944 AGGRESSION 8 0.0002
945 OVERDOSE 34 0.0002
946 CARDIOVASCULAR DISORDER 4 0.0002
947 FLUSHING 16 0.0002
948 PRODUCT USE ISSUE 29 0.0002
949 TOXICITY TO VARIOUS AGENTS 26 0.0002
950 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
951 ANGER 5 0.0001
952 DYSKINESIA 6 0.0001
953 BLOOD GLUCOSE DECREASED 7 0.0001
954 SKIN BURNING SENSATION 10 0.0001
955 HYPERSOMNIA 4 0.0001
956 SEIZURE 16 0.0001
957 BLOOD GLUCOSE INCREASED 26 0.0001
958 ASCITES 4 0.0001
959 DIABETES MELLITUS 10 0.0001
960 FEMUR FRACTURE 4 0.0001
961 VISUAL IMPAIRMENT 16 0.0001
962 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
963 OCULAR HYPERAEMIA 6 0.0001
964 DRUG DEPENDENCE 20 0.0001
965 DEATH 107 0.0001
966 INCORRECT DOSE ADMINISTERED 28 0.0001
967 DRUG ABUSE 10 0.0001
968 BONE PAIN 7 0.0001
969 ADVERSE EVENT 11 0.0001
970 EYE PRURITUS 4 0.0001
971 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
972 DRUG DOSE OMISSION 19 0.0001
973 INJECTION SITE HAEMORRHAGE 9 0.0001
974 ALOPECIA 22 0.0001
975 ACNE 8 0.0001
976 EYE IRRITATION 6 0.0001
977 PRODUCT SUBSTITUTION ISSUE 6 0.0001
978 DEVICE LEAKAGE 4 0.0001
979 DRUG WITHDRAWAL SYNDROME 8 0.0001
980 MULTIPLE SCLEROSIS 4 0.0001
981 ILL-DEFINED DISORDER 5 0.0001
982 INJECTION SITE PAIN 25 0.0001
983 INTENTIONAL PRODUCT MISUSE 7 0.0001
984 FLUID RETENTION 4 0.0001
985 INJECTION SITE REACTION 5 0.0001
986 INJECTION SITE ERYTHEMA 9 0.0001
987 ARTHROPATHY 4 0.0001
988 INJECTION SITE SWELLING 5 0.0001
989 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
990 PSORIASIS 8 0.0001
991 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
992 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
993 NO ADVERSE EVENT 6 0.0000